Pharmabiz21h
China NMPA clears Harbour BioMed’s IND application for HBM9378/SKB378 for chronic obstructive pulmonary disease treatment
Cambridge, Massachusetts Thursday, February 6, 2025, 13:00 Hrs [IST] ...
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) ...
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...
Mount Desert Islander2d
How NIH funding impacts local institutions
Hancock County's largest employer, The Jackson Laboratory, received nearly $82 million from 106 awards from the National ...